Efficacy and Safety of Saxagliptin as Monotherapy in Patients with Type 2 Diabetes: A Pooled Analysis

被引：0
|
作者：
Hirshberg, Boaz
Bryzinski, Brian
Xu, John
Monyak, John
Iqbal, Nayyar
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2403-PO
引用
收藏
页码：A610 / A610
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of saxagliptin added to thiazolidinedione over 76 weeks in patients with type 2 diabetes mellitus
    Hollander, Priscilla L.
    Li, Jia
    Frederich, Robert
    Allen, Elsie
    Chen, Roland
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (02): : 125 - 135
  • [42] Efficacy and safety of alogliptin monotherapy over 12 weeks in patients with type 2 diabetes
    Fleck, Penny
    Christopher, Ronald
    Covington, Paul
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2008, 57 : A143 - A143
  • [43] Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
    Kubota, Akira
    Maeda, Hajime
    Kanamori, Akira
    Matoba, Kiyokazu
    Jin, Yasuyuki
    Minagawa, Fuyuki
    Obana, Mitsuo
    Iemitsu, Kotaro
    Ito, Shogo
    Amamiya, Hikaru
    Kaneshiro, Mizuki
    Takai, Masahiko
    Kaneshige, Hideaki
    Hoshino, Kazuhiko
    Ishikawa, Masashi
    Minami, Nobuaki
    Takuma, Tetsuro
    Sasai, Nobuo
    Aoyagi, Sachio
    Kawata, Takehiro
    Mokubo, Atsuko
    Takeda, Hiroshi
    Honda, Shin
    Machimura, Hideo
    Motomiya, Tetsuya
    Waseda, Manabu
    Naka, Yoshikazu
    Tanaka, Yasushi
    Terauchi, Yasuo
    Matsuba, Ikuro
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (06) : 503 - 509
  • [44] Efficacy and Safety of Gosogliptin as Monotherapy and in Combination with Metformin in Patients with Type 2 Diabetes Mellitus
    Trakhtenberg, Julia
    Vostokova, Natalia
    Karavaeva, Oksana
    Kreminskaya, Vera
    Ametov, Alexander
    DIABETES, 2015, 64 : A329 - A330
  • [45] Efficacy and Safety of Antihyperglycemic Agents Added to Metformin Monotherapy in Patients with Type 2 Diabetes
    Mearns, Elizabeth S.
    Sobieraj, Diana M.
    White, C. Michael
    Saulsberry, Whitney J.
    Doleh, Yunes
    Zaccaro, Eric
    Coleman, Craig I.
    DIABETES, 2015, 64 : A658 - A658
  • [46] Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
    Samuel S Engel
    Gregory T Golm
    Deborah Shapiro
    Michael J Davies
    Keith D Kaufman
    Barry J Goldstein
    Cardiovascular Diabetology, 12
  • [47] Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
    Ona Kinduryte Schorling
    Douglas Clark
    Isabella Zwiener
    Stefan Kaspers
    Jisoo Lee
    Hristo Iliev
    Advances in Therapy, 2020, 37 : 3463 - 3484
  • [48] Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
    Kinduryte Schorling, Ona
    Clark, Douglas
    Zwiener, Isabella
    Kaspers, Stefan
    Lee, Jisoo
    Iliev, Hristo
    ADVANCES IN THERAPY, 2020, 37 (08) : 3463 - 3484
  • [49] Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
    Engel, Samuel S.
    Golm, Gregory T.
    Shapiro, Deborah
    Davies, Michael J.
    Kaufman, Keith D.
    Goldstein, Barry J.
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [50] Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease
    Toth, Peter P.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 9 - 23
12345